VC
Insider
Vlad Coric
DirectorVlad Coric (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in BHVN. Across 2 priced purchase filings, the average 21-session return was +37.0% from execution and +27.3% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of BHVN (666,666 sh across 2 lots, as filed), executed Nov 13 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+37.0%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+27.3%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Feb 5
Filed Feb 5
Median ADV $79.0M across their filed names
Open performance→Volume by month
Buys $7.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
1 filing
Sector per market data · by filing · past 12 months
Most traded names
BHVN
BHVN
1 buy · 0 sells
1 filing
MANERecent filings
MANEPURCHASE
Veradermics, Incorporated
View filing →
$2.0M117,646 sh across 2 lots
Exec Feb 5
Filed Feb 5 · 7:04 PM ET BHVNPURCHASE Biohaven Ltd. View filing → $5.0M
666,666 sh across 2 lots
Exec Nov 13 2025
Filed Nov 17 2025 · 7:30 AM ET